The assessment of the bone mineral density in anti-TNF-treated Rheumatoid arthritis and ankylosing spondylitis patients by peripheral quantitative computed tomography
Latest Information Update: 25 Jun 2021
At a glance
- Drugs Certolizumab pegol (Primary) ; Etanercept (Primary)
- Indications Ankylosing spondylitis; Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 25 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism.